Results of the first cannabidiol (CBD) bioavailability clinical trial on human subjects released
In January, TruGen3 announced the release of the first-ever clinical trial on healthy human subjects testing oral bioavailability of cannabidiol. CBD is known to have limited oral bioavailability due to its poor aqueous solubility and extensive first-pass metabolism. The August 2019 study published in the journal Molecules sought to determine whether the absorption of CBD […]











